Loading...

Vetoquinol S.A.

0O1O.L•LSE
Healthcare
Medical - Pharmaceuticals
£75.00
£-0.50(-0.66%)

Vetoquinol S.A. (0O1O.L) Stock Overview

Explore Vetoquinol S.A.’s financial performance, market position, analyst ratings, and future outlook.

Meyka AI Score

B+

Score: 72.5/100

Key Financials

Market Cap885M
P/E Ratio15.12
EPS (TTM)$5.32
ROE0.10%
Fundamental Analysis

AI Price Forecasts

1 Week$75.56
1 Month$66.06
3 Months$72.25
1 Year Target$77.73

0O1O.L Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of Vetoquinol S.A. (0O1O.L) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B+, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

The current technical analysis reveals key indicators including an RSI of 47.91, suggesting the stock is in a neutral condition. Our forecasting models predict significant price movements, with a 12-month target of $77.73.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of 15.12 and a market capitalization of 885M. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

Frequently Asked Questions

;